Global Vascular Stent Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Global Vascular Stent Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • October 2017 •
  • 190 pages •
  • Report ID: 5303693 •
  • Format: PDF
Vascular stents are majorly used in the treatment of vascular diseases such as, atherosclerosis and peripheral artery disease, blood clotting disorders, etc.

The global vascular stent market is expected to rise at a CAGR of about 7.5% during the forecast period 2016-2023.Rising prevalence of vascular diseases and growth in geriatric population across the globe majorly contributes to the market growth during forecast period. However, availability of alternative treatment methods for vascular diseases such as drug treatment, product failures and recalls are the factors restraining growth of global vascular stent market during forecast period.

Geographically, North America held the largest market revenue share for the vascular stent market in 2016 followed by Europe and is expected to dominate the market during forecast period. Countries such as United States and Canada contribute to the dominance of North America.

Dominance of North America, during the forecast period is witnessed due to rising prevalence of cardio vascular diseases. According to the Centers for Disease Control and Prevention (CDCP), United States, nearly 630,000 Americans die from heart disease each year (1 in every 4 deaths). Furthermore, Asia Pacific is expected to be the fastest growing region for stent market during the forecast period due to growing geriatric population in the region.

The growth in the global vascular stent market is also influenced by the presence of major players such as Microport Scientific Corporation (China), TransluminaGmbh (Germany), W.L. Gore And Associates, Inc. (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S), etc. To gain competitive advantage the major players adopt various strategies such as mergers & acquisitions, product launch, strategic partnership, collaboration, joint ventures, etc.

Global vascular stent market report covers segmentation analysis of type, product, and mode of delivery, material and end users. Report further covers segments of type which include drug-eluting stents, bare-metal stents and bioabsorbable stent.

Drug-eluting stent held the largest market share in terms of revenue in 2016 and is expected to dominate the type segment during the forecast period. The dominance is witnessed due to numerous advantages of drug-eluting stents over bare-metal stent such as s lower risk of restenosis, etc. Furthermore, Mode of delivery in vascular stent includes balloon expandable stents and self-expanding stents.

Balloon expandable stents segment is expected to grow at the highest rate during the forecast period. Fastest growth rate of balloon expandable stents is expected due to increasing regulatory approvals for balloon-expandable stents and its high usage in angioplasty procedures.